Luminex Corp
LMNXDelisted Jul 14, 2021- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001033905
Luminex Corp was delisted on Jul 14, 2021; its insiders filed their last Form 4 on Jul 15, 2021; 187 institutions reported holding it in 13F filings for Q2 2021, worth $1.56B in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:11 PM ET
Revenue flow, FY2020
Where the revenue went in FY2020, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2021 | Jan 13, 2020 | Jan 7, 2019 | Jan 8, 2018 | Jan 9, 2017 |
| Revenue | $417.4M | $334.6M | $315.8M | $306.6M | $270.6M |
| Cost of revenue | $169.5M | $151.9M | $120.3M | $107.5M | $91.0M |
| Gross profit | $247.9M | $182.7M | $195.5M | $199.0M | $179.7M |
| Operating expenses | $205.4M | $194.8M | $167.6M | $161.9M | $158.7M |
| Research and development | $53.7M | $56.2M | $47.2M | $45.7M | $48.7M |
| Selling, general and administrative | $140.2M | $127.2M | $111.8M | $107.3M | $99.5M |
| Operating income | $42.4M | -$12.1M | $27.8M | $37.2M | $21.0M |
| Interest expense | $11.5M | – | – | – | $0 |
| Income tax | $13.8M | -$5.66M | $9.80M | $7.73M | $5.80M |
| Net income | $15.2M | -$3.84M | $18.5M | $29.4M | $13.8M |
| EPS, basic | $0.33 | $-0.09 | $0.42 | $0.67 | $0.32 |
| EPS, diluted | $0.32 | $-0.09 | $0.41 | $0.67 | $0.32 |
| Weighted shares, basic | 45.1M | 44.1M | 43.7M | 43.2M | 42.6M |
| Weighted shares, diluted | 45.8M | 44.1M | 44.3M | 43.3M | 43.0M |
| Margins and growth | |||||
| Gross margin | 59.4% | 54.6% | 61.9% | 64.9% | 66.4% |
| Operating margin | 10.2% | -3.6% | 8.8% | 12.1% | 7.8% |
| Net margin | 3.6% | -1.1% | 5.9% | 9.6% | 5.1% |
| Revenue growth, year over year | +24.7% | +6.0% | +3.0% | +13.3% | +13.9% |
| Net income growth, year over year | – | −120.7% | −37.1% | +113.0% | −62.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2021 | Jan 13, 2020 | Jan 7, 2019 | Jan 8, 2018 | Jan 9, 2017 |
| Cash and equivalents | $309.4M | $59.2M | $76.4M | $127.1M | $93.5M |
| Short-term investments | – | – | – | – | $0 |
| Accounts receivable | $67.0M | $55.8M | $53.4M | $40.6M | $32.4M |
| Inventory | $123.1M | $77.1M | $63.3M | $49.5M | $40.8M |
| Total current assets | $509.0M | $202.5M | $202.7M | $224.6M | $173.7M |
| Property, plant and equipment | $64.1M | $65.5M | $66.3M | $58.3M | $57.4M |
| Goodwill | $118.1M | $118.1M | $118.1M | $85.5M | $85.5M |
| Intangible assets | $78.8M | $90.3M | $105.1M | $76.0M | $84.8M |
| Total assets | $825.5M | $543.7M | $525.2M | $490.5M | $450.7M |
| Accounts payable | $21.0M | $18.0M | $14.5M | $14.5M | $12.3M |
| Total current liabilities | $87.5M | $58.1M | $51.4M | $45.2M | $40.2M |
| Long-term debt | $203.1M | – | – | – | – |
| Total liabilities | $307.8M | $78.9M | $57.5M | $52.6M | $47.0M |
| Shareholders' equity | $517.7M | $464.9M | $467.7M | $437.9M | $403.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2021 | Jan 13, 2020 | Jan 7, 2019 | Jan 8, 2018 | Jan 9, 2017 |
| Operating cash flow | $49.9M | $13.5M | – | $57.4M | $49.7M |
| Capital expenditures | $17.9M | $16.2M | $21.3M | $14.6M | $13.1M |
| Free cash flow | $32.0M | -$2.71M | – | $42.8M | $36.6M |
| Depreciation and amortization | $30.5M | $28.5M | – | $22.6M | $20.1M |
| Stock-based compensation | $14.9M | $13.2M | $12.2M | $12.5M | $11.8M |
| Dividends paid | $16.5M | $12.2M | $10.7M | – | – |
| Share buybacks | – | – | – | $2.35M | $1.72M |
| Investing cash flow | -$17.9M | -$20.6M | – | -$17.1M | -$62.9M |
| Financing cash flow | $219.2M | -$10.5M | – | -$5.97M | -$21.6M |
| Net change in cash | $250.2M | -$17.3M | -$50.7M | $33.7M | -$35.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.6% | 3.9% | 3.9% | 4.1% | 4.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.